Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Oncolytics Biotech Inc ONCY


Primary Symbol: T.ONC

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and... see more

TSX:ONC - Post Discussion

Oncolytics Biotech Inc > Market Speaks
View:
Post by Quentin30 on May 15, 2024 12:26pm

Market Speaks

Whatever the pumper crowd on here are trying to spin this time... the market ONCE AGAIN tells you all you need to know..

Phase II/III, means more delay... Not quite the we will start phase III in Q1 2024 is it..?

Oh Matty Matty.. the stories you tell...  Ok, things are moving forward... but finally... WHERE is the partner... that is all we wanna know... who is gonna pay for this fustercluck of a trial.
Comment by Azzak34 on May 15, 2024 12:32pm
I thought I told you to go get your shinebox!! What did you learn about Master Protocol/ Adaptive Trials?  This better or worse then than the Pancan deal that we had a decent run-up on? 
Comment by 13X2413 on May 15, 2024 1:20pm
Is there any kind of news that will move the needle on this POS!? Any kind of news brings on more selling. Noteazz can't possibly put a positive spin on today. Another lunch bag let down. 
Comment by Azzak34 on May 15, 2024 1:27pm
Who.cares!!! I'm betting I'm right and Pela gets to market. Yours and the rest of the stooges argument is that it won't or worse, that the company is committing fraud. I'll be right. 
Comment by Buckhenry on May 15, 2024 1:36pm
The forever pumpers have spent thousands buying perfume to put on this POS for years and it still stinks 
Comment by Azzak34 on May 15, 2024 1:39pm
You're best at analogies Buckster.  That's now 2 major cancer charities who want to do business with us. Expedite and help fund trials, that's pretty good no? 
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities